Inhibition of LncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition

Overview

Journal Cancer Res Treat

Specialty Oncology

Date 2021 Mar 11

PMID 33705625

Citations 7

Authors

Deyu Li

Qin Tong

Yuane Lian

Zhizhong Chen

Yaru Zhu

Weimei Huang

Yang Wen

Qiongyao Wang

Shumei Liang

Man Li

Jianjing Zheng

Zhenhua Liu

Huanxin Liu

Linlang Guo

Affiliations

Soon will be listed here.

Abstract

Purpose: Drug resistance is one of the main causes of chemotherapy failure in patients with small cell lung cancer (SCLC), and extensive biological studies into chemotherapy drug resistance are required.

Materials And Methods: In this study, we performed lncRNA microarray, in vitro functional assays, in vivo models and cDNA microarray to evaluate the impact of lncRNA in SCLC chemoresistance.

Results: The results showed that KCNQ1OT1 expression was upregulated in SCLC tissues and was a poor prognostic factor for patients with SCLC. Knockdown of KCNQ1OT1 inhibited cell proliferation, migration, chemoresistance and promoted apoptosis of SCLC cells. Mechanistic investigation showed that KCNQ1OT1 can activate transforming growth factor-β1 mediated epithelial-to-mesenchymal transition in SCLC cells.

Conclusion: Taken together, our study revealed the role of KCNQ1OT1 in the progression and chemoresistance of SCLC, and suggested KCNQ1OT1 as a potential diagnostic and prognostic biomarker in SCLC clinical management.

Citing Articles

Molecular mechanism of ZC3H13 -mediated ferroptosis in doxorubicin resistance of triple negative breast cancer.

Huang L, Han L, Liang S, Han G Cell Biol Toxicol. 2025; 41(1):52.

PMID: 40000487 PMC: 11861033. DOI: 10.1007/s10565-024-09980-4.

A review of the complex interplay between chemoresistance and lncRNAs in lung cancer.

Alnefaie G J Transl Med. 2024; 22(1):1109.

PMID: 39639388 PMC: 11619437. DOI: 10.1186/s12967-024-05877-2.

Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1 pathway.

Li S, Lv J, Li Z, Zhang Q, Lu J, Huo X Mol Cancer. 2024; 23(1):243.

PMID: 39478582 PMC: 11526623. DOI: 10.1186/s12943-024-02145-1.

Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.

Liu Y, Ding W, Wang J, Ao X, Xue J Front Oncol. 2023; 13:1256537.

PMID: 37746261 PMC: 10514911. DOI: 10.3389/fonc.2023.1256537.

Hydroquinidine Demonstrates Remarkable Antineoplastic Effects on Non-small Cell Lung Cancer Cells.

Yavuz M, Demircan T Curr Mol Med. 2023; 24(9):1159-1168.

PMID: 37592773 DOI: 10.2174/1566524023666230817115937.

References

Zhuo W, Liu Y, Li S, Guo D, Sun Q, Jin J . Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS. Gastroenterology. 2018; 156(3):676-691.e11. DOI: 10.1053/j.gastro.2018.10.054. View

Sun Y, Hu B, Wang Q, Ye M, Qiu Q, Zhou Y . Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a. Cell Death Dis. 2018; 9(2):85. PMC: 5833383. DOI: 10.1038/s41419-017-0113-5. View

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

Zheng L, Zhang F, Wang L, Hu H, Lian Y . LncRNA KCNQ1OT1 is overexpressed in non-small cell lung cancer and its expression level is related to clinicopathology. Eur Rev Med Pharmacol Sci. 2019; 23(16):6944-6950. DOI: 10.26355/eurrev_201908_18734. View

Du B, Shim J . Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules. 2016; 21(7). PMC: 6273543. DOI: 10.3390/molecules21070965. View

Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T . Cancer Therapy Due to Apoptosis: Galectin-9. Int J Mol Sci. 2017; 18(1). PMC: 5297709. DOI: 10.3390/ijms18010074. View

Xu J, Lamouille S, Derynck R . TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009; 19(2):156-72. PMC: 4720263. DOI: 10.1038/cr.2009.5. View

Fang S, Gao H, Tong Y, Yang J, Tang R, Niu Y . Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells. Lab Invest. 2015; 96(1):60-8. DOI: 10.1038/labinvest.2015.123. View

Li Z, Zhang J, Liu X, Li S, Wang Q, Chen D . The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nat Commun. 2018; 9(1):1572. PMC: 5910401. DOI: 10.1038/s41467-018-04006-0. View

10.

Park J, Kim Y, Park E, Lee S, Kim H, Kim A . Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer. Cancer Sci. 2019; 110(9):2834-2845. PMC: 6726705. DOI: 10.1111/cas.14124. View

11.

Sabari J, Lok B, Laird J, Poirier J, Rudin C . Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017; 14(9):549-561. PMC: 5843484. DOI: 10.1038/nrclinonc.2017.71. View

12.

Sun H, Li Y, Kong H, Dai S, Qian H . Dysregulation of KCNQ1OT1 promotes cholangiocarcinoma progression via miR-140-5p/SOX4 axis. Arch Biochem Biophys. 2018; 658:7-15. DOI: 10.1016/j.abb.2018.09.019. View

13.

Xian D, Zhao Y . LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway. J Cell Mol Med. 2019; 23(6):3808-3823. PMC: 6533496. DOI: 10.1111/jcmm.14071. View

14.

Zeng F, Wang Q, Wang S, Liang S, Huang W, Guo Y . Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene. 2019; 39(2):293-307. DOI: 10.1038/s41388-019-0984-2. View

15.

Luo Z, Jin H . Effects of LncRNA KCNQ1OT1 on proliferation and migration of ovarian cancer cells by Wnt/β-catenin. Eur Rev Med Pharmacol Sci. 2019; 23(20):8788-8794. DOI: 10.26355/eurrev_201910_19273. View

16.

Sun Y, Zhou Y, Bai Y, Wang Q, Bao J, Luo Y . A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients. Mol Cancer. 2017; 16(1):162. PMC: 5646126. DOI: 10.1186/s12943-017-0729-1. View

17.

Wang J, Zhang H, Situ J, Li M, Sun H . KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis. Cancer Cell Int. 2019; 19:325. PMC: 6889643. DOI: 10.1186/s12935-019-1039-z. View

18.

Liu H, Chen R, Kang F, Lai H, Wang Y . KCNQ1OT1 promotes ovarian cancer progression via modulating MIR-142-5p/CAPN10 axis. Mol Genet Genomic Med. 2020; 8(2):e1077. PMC: 7005641. DOI: 10.1002/mgg3.1077. View

19.

Guo B, Zhang Q, Wang H, Chang P, Tao K . KCNQ1OT1 promotes melanoma growth and metastasis. Aging (Albany NY). 2018; 10(4):632-644. PMC: 5940105. DOI: 10.18632/aging.101418. View

20.

Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A . Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. Lancet Oncol. 2017; 18(8):1116-1125. PMC: 5555437. DOI: 10.1016/S1470-2045(17)30318-2. View